Nfkb2 deficiency and its impact on plasma cells and immunoglobulin expression in murine small intestinal mucosa
暂无分享,去创建一个
J. Caamaño | J. Hernandez-Fernaud | N. Gupta | D. Pritchard | S. Papoutsopoulou | C. Probert | Raheleh Sheibani-Tezerji | C. Duckworth | W. Muller | Joseph M. Tang | Jonathan M. Williams | AH Elramli | Felix I Ikuomola | M. Alam
[1] G. Ghosh,et al. Origin of the Functional Distinctiveness of NF-κB/p52 , 2021, Frontiers in Cell and Developmental Biology.
[2] Mariano Martín,et al. Integrated Design of Biorefineries Based on Spent Coffee Grounds , 2021 .
[3] D. Fox,et al. Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family. , 2020, Rheumatology.
[4] A. Waisman,et al. Investigating the importance of B cells and antibodies during Trichuris muris infection using the IgMi mouse , 2020, Journal of Molecular Medicine.
[5] G. Sauter,et al. Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues , 2019, Disease markers.
[6] J. Caamaño,et al. NF-κB2 signalling in enteroids modulates enterocyte responses to secreted factors from bone marrow-derived dendritic cells , 2019, Cell Death & Disease.
[7] Peter D. Pioli. Plasma Cells, the Next Generation: Beyond Antibody Secretion , 2019, Front. Immunol..
[8] Alexandra M. E. Jones,et al. Phosphoregulation of tropomyosin is crucial for actin cable turnover and division site placement , 2019, The Journal of cell biology.
[9] Chen-chen Gao,et al. Function and dysfunction of plasma cells in intestine , 2019, Cell & Bioscience.
[10] Nupur K. Das,et al. Intestinal non-canonical NFκB signaling shapes the local and systemic immune response , 2019, Nature Communications.
[11] Martin Eisenacher,et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data , 2018, Nucleic Acids Res..
[12] N. Giltiay,et al. CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity , 2018, Front. Immunol..
[13] Shao-Cong Sun,et al. NIK signaling axis regulates dendritic cell function in intestinal immunity and homeostasis , 2018, Nature Immunology.
[14] S. Basak,et al. The NF-κB Activating Pathways in Multiple Myeloma , 2018, Biomedicines.
[15] Acknowledgement to Reviewers of Biomedicines in 2017 , 2018, Biomedicines.
[16] Marc Pybus,et al. Human Secretory IgM Emerges from Plasma Cells Clonally Related to Gut Memory B Cells and Targets Highly Diverse Commensals , 2017, Immunity.
[17] Shao-Cong Sun,et al. The non-canonical NF-κB pathway in immunity and inflammation , 2017, Nature Reviews Immunology.
[18] Xia Yang,et al. Extended Multiplexing of Tandem Mass Tags (TMT) Labeling Reveals Age and High Fat Diet Specific Proteome Changes in Mouse Epididymal Adipose Tissue* , 2017, Molecular & Cellular Proteomics.
[19] Jüergen Cox,et al. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics , 2016, Nature Protocols.
[20] Marc-Thorsten Hütt,et al. Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease , 2016, Gut.
[21] I. C. Allen,et al. Emerging Roles for Noncanonical NF-&kgr;B Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology , 2016, Inflammatory Bowel Diseases.
[22] U. Klein,et al. Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development , 2016, Proceedings of the National Academy of Sciences.
[23] Marco Y. Hein,et al. The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.
[24] David S. Wishart,et al. Heatmapper: web-enabled heat mapping for all , 2016, Nucleic Acids Res..
[25] Simon Mitchell,et al. Signaling via the NFκB system , 2016, Wiley interdisciplinary reviews. Systems biology and medicine.
[26] G. Núñez,et al. Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens. , 2016, Immunity.
[27] J. Caamaño,et al. NF‐κB1, NF‐κB2 and c‐Rel differentially regulate susceptibility to colitis‐associated adenoma development in C57BL/6 mice , 2015, The Journal of pathology.
[28] G. Superti-Furga,et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity , 2014, Nature Communications.
[29] M. Field,et al. Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100. , 2014, Blood.
[30] Kejian Zhang,et al. Combined Immune Deficiency in a Patient with a Novel NFKB2 Mutation , 2014, Journal of Clinical Immunology.
[31] Kejian Zhang,et al. Combined Immune Deficiency in a Patient with a Novel NFKB2 Mutation , 2014, Journal of Clinical Immunology.
[32] E. Butcher,et al. Transcriptional programs of lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homing , 2014, Nature Immunology.
[33] T. Macdonald,et al. Plasma Cells in the Mucosa of Patients with Inflammatory Bowel Disease Produce Granzyme B and Possess Cytotoxic Activities , 2014, The Journal of Immunology.
[34] Andrew R. Jones,et al. ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination , 2014, Nature Biotechnology.
[35] I. Delladetsima,et al. CD138 (syndecan-1) expression in health and disease. , 2014, Histology and histopathology.
[36] Emily M. Coonrod,et al. Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency. , 2013, American journal of human genetics.
[37] R. Sutton,et al. A mouse model of pathological small intestinal epithelial cell apoptosis and shedding induced by systemic administration of lipopolysaccharide , 2013, Disease Models & Mechanisms.
[38] Hongbo Hu,et al. Otud7b controls noncanonical NF-κB activation via deubiquitination of TRAF3 , 2013, Nature.
[39] T. Hibi,et al. Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation , 2012, Gut.
[40] M. Elsalanty,et al. NF-κB2 mutation targets survival, proliferation and differentiation pathways in the pathogenesis of plasma cell tumors , 2012, BMC Cancer.
[41] M. Elsalanty,et al. NF-κB2 mutation targets survival, proliferation and differentiation pathways in the pathogenesis of plasma cell tumors , 2012, BMC Cancer.
[42] M. Karin,et al. NF‐κB and the link between inflammation and cancer , 2012, Immunological reviews.
[43] Shao-Cong Sun. The noncanonical NF‐κB pathway , 2012, Immunological reviews.
[44] J. Ragoussis,et al. Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-κB family DNA binding , 2011, Nature Immunology.
[45] K. Lundin,et al. Long-Lived Plasma Cells from Human Small Intestine Biopsies Secrete Immunoglobulins for Many Weeks In Vitro , 2011, The Journal of Immunology.
[46] Marcel Martin. Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .
[47] A. Watson,et al. The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. , 2011, Gastroenterology.
[48] S. Ghosh,et al. NF-κB in immunobiology , 2011, Cell Research.
[49] T. Lawrence. The nuclear factor NF-kappaB pathway in inflammation. , 2009, Cold Spring Harbor perspectives in biology.
[50] Lior Pachter,et al. Sequence Analysis , 2020, Definitions.
[51] V. Makeev,et al. In vitro selection of optimal RelB/p52 DNA-binding motifs. , 2008, Biochemical and biophysical research communications.
[52] Lennart Martens,et al. The minimum information about a proteomics experiment (MIAPE) , 2007, Nature Biotechnology.
[53] S. Gerondakis,et al. Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models , 2006, Oncogene.
[54] Shao-Cong Sun,et al. β-TrCP binding and processing of NF-κB2/p100 involve its phosphorylation at serines 866 and 870 , 2006 .
[55] S. Ley,et al. Functions of NF-?B1 and NF-?B2 in immune cell biology , 2004 .
[56] Bodo B. Schlegelmilch,et al. Reactions to unethical consumer behavior across six countries , 2004 .
[57] G. Xiao,et al. Induction of p100 Processing by NF-κB-inducing Kinase Involves Docking IκB Kinase α (IKKα) to p100 and IKKα-mediated Phosphorylation* , 2004, Journal of Biological Chemistry.
[58] Hans Lehrach,et al. A comparison of oligonucleotide and cDNA-based microarray systems. , 2004, Physiological genomics.
[59] G. Pinkus,et al. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. , 2004, American journal of clinical pathology.
[60] J. Caamaño,et al. Regulation of secondary lymphoid organ development by the nuclear factor‐κB signal transduction pathway , 2003, Immunological reviews.
[61] F. Weih,et al. RelB is required for Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and TNF , 2003, The EMBO journal.
[62] C. Hunter,et al. Differential Requirement for NF-κB Family Members in Control of Helminth Infection and Intestinal Inflammation1 , 2002, The Journal of Immunology.
[63] R. Schmid,et al. Abnormal organogenesis of Peyer's patches in mice deficient for NF-κB1, NF-κB2, and Bcl-3 , 2002 .
[64] Michael Karin,et al. Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.
[65] E. Harhaj,et al. NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .
[66] Jerilyn A. Walker,et al. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). , 2000, BioTechniques.
[67] C. Snapper,et al. Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses , 1998, The Journal of experimental medicine.
[68] D. Carrasco,et al. Gastric Hyperplasia and Increased Proliferative Responses of Lymphocytes in Mice Lacking the COOH-terminal Ankyrin Domain of NF-κB2 , 1997, The Journal of experimental medicine.
[69] A. Forbes,et al. Expression of Syndecan-1 in Inflammatory Bowel Disease and a Possible Mechanism of Heparin Therapy , 1997, Digestive Diseases and Sciences.
[70] F. Weih,et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.
[71] R. Sanderson,et al. Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[72] D. Wessel,et al. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. , 1984, Analytical biochemistry.
[73] P. Park,et al. Molecular functions of syndecan-1 in disease. , 2012, Matrix biology : journal of the International Society for Matrix Biology.
[74] T. Lawrence. The Nuclear Factor NF-kB Pathway in Inflammation , 2009 .
[75] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.
[76] D. Dudley,et al. The immune system in health and disease. , 1992, Bailliere's clinical obstetrics and gynaecology.